DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the CHANDAN HEALTHCARE LTD (CHANDAN) share price today?

CHANDAN HEALTHCARE LTD (CHANDAN) is trading at ₹231.4 on the NSE, down 4.18% on the day. Source: DocStoX.

What is the PE ratio of CHANDAN HEALTHCARE LTD?

CHANDAN HEALTHCARE LTD has a price-to-earnings (PE) ratio of 20.9 in the Healthcare Services sector.

What is the market capitalisation of CHANDAN HEALTHCARE LTD?

CHANDAN HEALTHCARE LTD has a market capitalisation of approximately ₹624 crore.

CHANDAN HEALTHCARE LTD

CHANDAN·NSE·Healthcare Services

₹231.40▼ -10.10 (-4.18%)

Healthcare Services · Healthcare Service Provider

Revenue compounding 26% a year

Day₹231.00

₹244.50

52W₹185

₹35827%

Open

₹241.50

High

₹244.50

Low

₹231.00

Prev Close

₹241.50

Volume

68.8K

VWAP

₹237.62

Snapshot

Key fundamentals

Market Cap

₹624 Cr

P/E Ratio

20.90Fair

P/B Ratio

3.66

EPS

₹11.07

Book Value

₹69.90

ROE

19.90%Strong

ROCE

23.00%Efficient

Dividend Yield

0.00%

Debt / Equity

0.32Moderate

Face Value

₹10.00

52W High

₹358.00

52W Low

₹185.40

Sector

Healthcare Services

Industry

Healthcare Service Provider

Avoid

Narrow moatMedium uncertainty

Fair value estimate

₹104

▼ 55.1%downside

Trading at ₹231 — 55% above our estimate

BearFair valueBull

₹88₹104₹132

/100

Business quality — Solid

Growth 100Profitability 59Efficiency 38Valuation 78

Plain English

Our view

Revenue compounding 26% a year
Low debt relative to equity
Fundamental red flags (Piotroski 1/9)

Strengths

Low debt relative to equity
Capital is working hard (ROCE 23%)
Revenue compounding 26% over 3 years
Profit growing 108% a year

Risks

Fundamental red flags (Piotroski 1/9)

How we got there

Fair value methods

Residual income

20% ROE fading to 13% over ~10 yrs, on ₹70 book

₹96

Relative P/E

Needs ≥3 peers with P/E

—

Graham floor

Conservative floor: √(22.5 × EPS × book value/share)

₹132

Analyst target

No analyst coverage

—

Blended fair value₹104

What the numbers say

Investment thesis

Bull case

Low debt relative to equity
Capital is working hard (ROCE 23%)
Revenue compounding 26% over 3 years
Profit growing 108% a year

Bear case

Fundamental red flags (Piotroski 1/9)

Free — see our deterministic Fair Value range, business quality score, and the full bull/bear case for this stock.

Snapshot

Key statistics

P/E

20.9Fair

Below 15× is value territory; above 35× prices in strong growth

ROE

19.9%Strong

Above 15% is considered healthy for Indian equities

ROCE

23.0%Efficient

Above 18% means capital is working hard

Debt/Eq

0.32Moderate

Below 0.5 is comfortable; above 1.5 strains the balance sheet

Mkt Cap

₹624 Cr

P/B

3.66

EPS

₹11.07

Div Yield

—

What changed

Recent changes

Promoters+0.06% stake last quarter

What matters

News impact

Overview

Valuation

Reasonable

P/E 20.9×

Growth

Strong

+26% rev CAGR

Profitability

Excellent

19.9% ROE

Financial health

Comfortable

D/E 0.32

Momentum

N/A

No technicals

Today

Trading activity

Delivery %62.8%

Turnover₹163.48L Cr

Trades80

VWAP₹237.62

Face value₹10.00

Market depth

Market depth available during market hours

Snapshot

Technical signals

Compounded annual growth

Growth (CAGR)

Revenue

+26.3%

—

10Y

—

Profit

+108.0%

—

10Y

—

EPS

+87.5%

—

10Y

—

Profile

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 25.8%

Watch-outs

Cons

Though the company is reporting repeated profits, it is not paying out dividend
Debtor days have increased from 82.4 to 114 days.
Working capital days have increased from 61.8 days to 111 days

Forecast

News

Peers

Financials

Growth

Shareholding

Ownership

Ownership breakdown

Quarter ending 30 Jun 2026

Promoters raised their stake by 0.06 pts last quarter. The QoQ column shows each group's change versus the prior quarter.

50%

Promoter

Promoters

49.6%+0.06

Public

45.3%-0.13

FII / FPI

0.0%0.00

DII

5.1%+0.06

Quarterly trend

Ownership over time

Q1 FY27

Promoter49.61%

FII0.01%

DII5.09%

Public45.29%

Corporate Actions

Bulk & Block Deals

Filings

MF Holdings

Technicals

FAQs

Quick reference

Frequently asked questions

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]